Skip to main content
logo
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
68.79
+2.31 (3.47%)
At close: Sep 21, 2026, 4:00 PM EDT
68.51
-0.28 (-0.41%)
After-hours: Sep 21, 2026, 7:36 PM EDT

Arrowhead Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-319.96-1.63-599.49-205.28-176.06-140.85
Depreciation & Amortization
25.823.9318.612.4910.428.27
Loss (Gain) From Sale of Assets
-19-----
Loss (Gain) From Sale of Investments
0.39-0.08-4.43-1.71
Stock-Based Compensation
7063.3773.9778.13120.8976.67
Other Operating Activities
130.61112.1218.9112.312.480.27
Change in Accounts Receivable
-49.03-56.97-1.418.85-9.41
Change in Accounts Payable
-5.46.29-5.5433-6.592.63
Change in Unearned Revenue
103.362.4-0.87-129.18-112.5223.26
Change in Other Net Operating Assets
-6.4430.0531.4943.2311.9512.19
Operating Cash Flow
-59.06179.55-462.85-153.89-136.13171.31
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Capital Expenditures
-16.06-22.67-141.47-176.74-52.78-23.57
Investment in Securities
-785.67-106.63-278.680.5847.36-118.11
Investing Cash Flow
-801.72-129.29-420.07-96.16-5.42-141.68

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Short-Term Debt Issued
-10.26----
Long-Term Debt Issued
--392---
Total Debt Issued
703.1610.26392---
Long-Term Debt Repaid
--201.63----
Net Debt Issued (Repaid)
585.27-191.37392---
Issuance of Common Stock
219.38245.37431.653.055.1911.31
Other Financing Activities
-20.462046.8725060-
Financing Cash Flow
784.1974.01870.52253.0565.1911.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Foreign Exchange Rate Adjustments
1.56-0.44.2-0.12-0.07-0.09
Net Cash Flow
-75.03123.86-8.212.89-76.4340.85

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Free Cash Flow
-75.11156.89-604.32-330.63-188.91147.75
Free Cash Flow Growth
------
Free Cash Flow Margin
-11.22%18.92%-17018.31%-137.34%-77.67%106.84%
Free Cash Flow Per Share
-0.541.17-5.04-3.10-1.791.42
Levered Free Cash Flow
-48.6396.15-440.13-251.42-60.6463
Unlevered Free Cash Flow
7.83152-419.91-239.96-60.6463

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash Interest Paid
-0.02----
Cash Income Tax Paid
20.69-0.813.74-00
Change in Working Capital
42.49-18.2425.09-51.55-98.29228.66
SEC Filings: 10-K · 10-Q